
Opinion|Videos|January 2, 2025
Evolving Treatment Paradigms in Ph+ ALL
Dr. Bijal Shah explores the recent advancements and shifts in treatment strategies for Ph+ ALL, driven by innovations in targeted therapies and evolving clinical practices
Advertisement
- How has the treatment approach for Ph+ ALL evolved in recent years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma
2
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
3
Social Determinants of Health Linked to Worse Outcomes in Hypertrophic Cardiomyopathy
4
Subjective and Objective Impacts of Ambulatory AI Scribes
5





























































